General Information
Semaglutide (sold under brand names Ozempic® (Injection) and Rybelsus® (Oral) is a recombinant DNA produced polypeptide analogue of human glucagon-like peptide-1 (GLP-1) which is used in the therapy of type 2 diabetes.
About the API
Trade name(s)
Ozempic
Technology
Peptide
Molecular Formula
C187H291N45O59
Molecular Weight
4114 g/mol
Physical properties
Small Molecule
Therapeutic category
Diabetes
Available formulations
Injectables